The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer
新型 BET-CBP/p300 双重抑制剂 NEO2734 对 SPOP 突变型和野生型前列腺癌均有活性
期刊:EMBO Molecular Medicine
影响因子:9
doi:10.15252/emmm.201910659
Yuqian Yan, Jian Ma, Dejie Wang, Dong Lin, Xiaodong Pang, Shangqian Wang, Yu Zhao, Lei Shi, Hui Xue, Yunqian Pan, Jun Zhang, Claes Wahlestedt, Francis J Giles, Yu Chen, Martin E Gleave, Collin C Collins, Dingwei Ye, Yuzhuo Wang, Haojie Huang